HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Initial Assessment of Daily Insulin Dose in Chinese Newly Diagnosed Type 2 Diabetes.

AbstractBACKGROUND:
It has been well accepted that insulin therapy is the ideal treatment for newly diagnosed diabetic patients. However, there was no study about assessment of the initial insulin dosage in new onset Chinese patients with type 2 diabetes.
RESEARCH DESIGN AND METHODS:
65 newly diagnosed patients with type 2 diabetes (39 males/26 females; HbA1c ≥ 11.80 ± 0.22%) were investigated. All patients had random hyperglycaemia (at 21.8 ± 3.9 mmol/L) on the first day of admission and received insulin infusion intravenously (5 U/per hour). When the blood glucose level dropped to around 10 mmol/L, patients were then transferred to continuous subcutaneous insulin infusion (CSII). The reduction of blood glucose levels in response to per unit of insulin (RBG/RI) was recorded. The target glucose level was achieved in about 3 days. The total daily insulin dose (TDD) and basal insulin dose (TBD) were calculated.
RESULTS:
TDD was 45.97 ± 1.28 units and TBD was 19.00 ± 0.54 units. TBD was about 40% of the total daily insulin requirement. There was a negative correlation between the ratio of RBG/RI and TDD.
CONCLUSIONS:
TDD was correlated with blood glucose reduction in response to intravenous insulin infusion in Chinese new onset patients with type 2 diabetes.
AuthorsJing Ma, Huan Zhou, Hua Xu, Xie Chen, Xiangyu Teng, Qianjing Liu, Wei Liu
JournalJournal of diabetes research (J Diabetes Res) Vol. 2016 Pg. 7245947 ( 2016) ISSN: 2314-6753 [Electronic] England
PMID26697503 (Publication Type: Journal Article)
Chemical References
  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin
Topics
  • Blood Glucose
  • China
  • Diabetes Mellitus, Type 2 (drug therapy)
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Humans
  • Hyperglycemia (drug therapy)
  • Hypoglycemic Agents (administration & dosage, therapeutic use)
  • Insulin (administration & dosage, therapeutic use)
  • Male
  • Middle Aged
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: